hTERT Expression in Human Breast Cancer and Non-Cancerous Breast Tissue: Correlation with Tumour Stage and c-Myc Expression
Abstract
Telomerase is a ribonucleoprotein enzyme that synthesises telomeres after cell division and maintains chromosomal length and stability thus leading to cellular immortalisation. hTERT (human telomerase reverse transcriptase) gene is the rate-limiting determinant of telomerase reactivation. The present study aims to quantitatively measure the expression of hTERT mRNA in human breast cancer, adjacent non-cancerous tissue (ANCT) and benign breast lesions, examine the association between hTERT and the clinicopathological characteristics of the cancer specimens and to explore the relationship between c-Myc and hTERT expressions. RNA was extracted from 49 breast carcinomas, 46 matched ANCT, and eight fibroadenomas. hTERT and c-Myc mRNA expressions were estimated by reverse transcriptase-PCR (RT-PCR) and Taqman methodology. hTERT mRNA was present in all of the cancerous and most of ANCT specimens with levels being much higher in the cancerous tissue than in ANCT. The ratio of hTERT mRNA in tumour to that in ANCT was 2011 (95% confidence interval 373-10,853, P < 0.0001). There was no significant association between tumour hTERT expression and patient's age, tumour size, grade, nodal metastasis, estrogen receptor (ER) positivity, lymphovascular (LVI) or c-Myc expression. However, there was a weak but significant negative correlation between hTERT expression and progesterone receptor (PR) status (p = 0.04) in tumours. hTERT mRNA expression was also significantly higher in carcinomas (median = 2.61 x 10(6)) than in fibroadenomas (median = 424).We conclude that hTERT mRNA expression is significantly higher in human breast cancer than in non-cancerous breast tissue suggesting that hTERT has a potential role in breast cancer diagnosis. The hTERT mRNA levels in tumour do not seem to be associated with the patient's age or advanced tumour stage. Furthermore, hTERT mRNA expression does not correlate with c-Myc mRNA expression in breast cancer.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Myc and hTERT expression levels are not necessarily tightly correlated in some cancer cells.
“However, several studies found that Myc and hTERT expression levels are not necessarily tightly correlated in some cancer cells.(20,21)”
From Understanding and exploiting <i>hTERT</i> promoter regulation for diagnosis and treatment of human cancers (2008) · cites this paper as [20]
Cites
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975 · see citing works
Telomerase Catalytic Subunit Homologs from Fission Yeast and Human
Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., & Cech, T. R. (1997) · Science · doi:10.1126/science.277.5328.955 · Cited by 2,256 · see citing works
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227 · see citing works
Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80538-3 · Cited by 1,784 · see citing works
Direct activation of TERT transcription by c-MYC
Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R. (1999) · Nature Genetics · doi:10.1038/6010 · Cited by 893 · see citing works
Auboeuf, D., Rieusset, J., Lluis Fajas, A., Vallier, P., Fréring, V., Riou, J. P., Staels, B., Auwerx, J. H., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 699 · see citing works
A Mammalian Telomerase-Associated Protein
Harrington, L. A., McPhail, T., Mar, V. L., Zhou, W., Oulton, R., Program, A. E., Bass, M. B., Arruda, I., & Robinson, M. O. (1997) · Science · doi:10.1126/science.275.5302.973 · Cited by 666 · see citing works
Myc activates telomerasePreprint
Wang, J., Xie, L. Y., Allan, S., Beach, D., & Hannon, G. J. (1998) · Genes & Development · doi:10.1101/gad.12.12.1769 · Cited by 653 · see citing works
Kilian, A., Bowtell, D. D. L., Abud, H. E., Hime, G. R., Venter, D. J., Keese, P., Duncan, E. L., Reddel, R. R., & Jefferson, R. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.12.2011 · Cited by 586 · see citing works
Cong, Y. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.137 · Cited by 485 · see citing works
Counter, C. M., Meyerson, M. M., Eaton, E. N., Ellisen, L. W., Dickinson, S., Haber, D. A., & Weinberg, R. A. (1998) · Oncogene · doi:10.1038/sj.onc.1201882 · Cited by 421 · see citing works
Greenberg, R. A., O’Hagan, R. C., Deng, H., Xiao, Q., Hann, S. R., Adams, R. R., Lichtsteiner, S., Chin, L., Morin, G. B., & DePinho, R. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202669 · Cited by 411 · see citing works
Le, S., Moore, J. K., Haber, J. E., & Greider, C. W. (1999) · Genetics · doi:10.1093/genetics/152.1.143 · Cited by 410 · see citing works
Putnam, J. B., Light, R. W., Rodriguez, R. M., Ponn, R. B., Olak, J., Pollak, J. S., Lee, R. B., Payne, D. K., Graeber, G., & Kovitz, K. L. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991115)86:10 · Cited by 385 · see citing works
Expression of TERT in early premalignant lesions and a subset of cells in normal tissues
Kolquist, K. A., Ellisen, L. W., Counter, C. M., Meyerson, M. M., Tan, L. K., Weinberg, R. A., Haber, D. A., & Gerald, W. L. (1998) · Nature Genetics · doi:10.1038/554 · Cited by 382 · see citing works
Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening
Zhu, J., Wang, H., Bishop, J. M., & Blackburn, E. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3723 · Cited by 381 · see citing works
Xu, D., Popov, N., Hou, M., Wang, Q., Björkholm, M., Gruber, A., Menkel, A. R., & Arsenian‐Henriksson, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071043198 · Cited by 324 · see citing works
Liu, K., Schoonmaker, M. M., Levine, B. L., June, C. H., Hodes, R. J., & Weng, N.-P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.5147 · Cited by 233 · see citing works
The hTERTα Splice Variant is a Dominant Negative Inhibitor of Telomerase Activity
Colgin, L. M., Wilkinso, C., Englezou, A., Kilian, A., Robinson, M. O., & Reddel, R. R. (2000) · Neoplasia · doi:10.1038/sj.neo.7900112 · Cited by 228 · see citing works
Güneş, Ç., Lichtsteiner, S., Vasserot, A. P., & Englert, C. (2000) · PubMed · Cited by 217 · see citing works
Bièche, I., Noguès, C., Paradis, V., Olivi, M., Bédossa, P., Lidereau, R., & Vidaud, M. (2000) · PubMed · Cited by 185 · see citing works
Bustin, S. A., Gyselman, V. G., Williams, N. S., & Dorudi, S. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6990289 · Cited by 148 · see citing works
Self-citationTelomerase Activity and Survival of Patients With Node-Positive Breast Cancer
Clark, G. M., Osborne, C. K., Levitt, D., Wu, F., & Kim, N. W. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.24.1874 · Cited by 139 · see citing works
Snijders, P. J. F., van Duin, M., Walboomers, J. M. M., Steenbergen, R. D. M., Risse, E. K. J., Helmerhorst, T. J. M., Verheijen, R. H. M., & Meijer, C. J. L. M. (1998) · PubMed · Cited by 132 · see citing works
Visual inspection with acetic acid in the early detection of cervical cancer and precursors
Sankaranarayanan, R., Shyamalakumary, B., Wesley, R., Amma, N. S., Parkin, D. M., & Nair, M. K. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990105)80:1 · Cited by 114 · see citing works
van de Vaart, P. J. M., Belderbos, J. S. A., de Jong, D., Sneeuw, K. C. A., Majoor, D. M., Bartelink, H. G. M. M., & Begg, A. C. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000320)89:2 · Cited by 102 · see citing works
Recombination in telomere-length maintenance
Kass-Eisler, A., & Greider, C. W. (2000) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01557-7 · Cited by 100 · see citing works
Direct Examination of Histone Acetylation on Myc Target Genes Using Chromatin Immunoprecipitation
Eberhardy, S. R., D'Cunha, C. A., & Farnham, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005154200 · Cited by 91 · see citing works
Ducrest, A., Amacker, M., Mathieu, Y., Cuthbert, A. P., Trott, D. A., Newbold, R. F., Nabholz, M., & Lingner, J. (2001) · PubMed · Cited by 85 · see citing works
Self-citationBártková, J., Thullberg, M., Meyts, E. R., Skakkebæk, N. E., & Bartek, J. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000201)85:3 · Cited by 70 · see citing works
The significance of human telomerase reverse transcriptase (hTERT) in cancer
Kirkpatrick, K. L., & Mokbel, K. (2001) · European Journal of Surgical Oncology · doi:10.1053/ejso.2001.1151 · Cited by 69 · see citing works
Self-citationMokbel, K., Parris, C. N., Ghilchik, M. W., Williams, G., & Newbold, R. F. (1999) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)00128-2 · Cited by 55 · see citing works
Self-citationTelomerase activity and lymphovascular invasion in breast cancer
Mokbel, K., Parris, C. N., Ghilchik, M., Amerasinghe, C., & Newbold, R. F. (2000) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0736 · Cited by 41 · see citing works
Self-citationThe role of telomerase in breast cancer
Mokbel, K. (2000) · European Journal of Surgical Oncology · doi:10.1053/ejso.1999.0932 · Cited by 29 · see citing works
Self-citationMokbel, K., Ghilchik, M., Williams, G., Akbar, N., Parris, C. N., & Newbold, R. F. (2000) · PubMed · Cited by 18 · see citing works
Self-citationMutations of the human MUT S homologue 6 gene in ampullary carcinoma and gastric cancer
Imai, Y., Inoue, T., & Ishikawa, T. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981123)78:5 · Cited by 7 · see citing works
Flagged first, then by citations
1 of the 37 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347 · see citing works
Regulation of the human catalytic subunit of telomerase (hTERT)
Daniel, M. G., Peek, G. W., & Tollefsbol, T. O. (2012) · Gene · doi:10.1016/j.gene.2012.01.095 · Cited by 265 · see citing works
Zhang, Y., Toh, L.-L., Lau, P., & Wang, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.368282 · Cited by 181 · see citing works
Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened
Gonnissen, A., Isebaert, S. F., & Haustermans, K. M. (2015) · Oncotarget · doi:10.18632/oncotarget.4224 · Cited by 176 · see citing works
Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC
Khattar, E., & Tergaonkar, V. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00001 · Cited by 152 · see citing works
Telomerase regulation at the crossroads of cell fate
Ćukušić, A., Vidaček, N. Š., Sopta, M., & Rubelj, I. (2008) · Cytogenetic and Genome Research · doi:10.1159/000167812 · Cited by 80 · see citing works
Epigenetic Mechanism Involved in the HBV/HCV-Related Hepatocellular Carcinoma Tumorigenesis
Liang, R., Huang, N., Li, Z., Ji, F., & Shiwen, J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990533 · Cited by 75 · see citing works
Targeting telomerase for its advent in cancer therapeutics
Bajaj, S., Kumar, M. S., Peters, G. J., & Mayur, Y. (2020) · Medicinal Research Reviews · doi:10.1002/med.21674 · Cited by 71 · see citing works
Deng, W., Jayachandran, G., Wu, G., Xu, K., Roth, J. A., & Ji, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610579200 · Cited by 69 · see citing works
The role of telomeres and telomerase in the pathology of human cancer and aging
Shin, J., Hong, A., Solomon, M. J., & Lee, C. S. (2006) · Pathology · doi:10.1080/00313020600580468 · Cited by 65 · see citing works
Wei, C.-W., Lin, C.-C., Yu, Y.-L., Lin, P.-C., Lin, P.-C., Wu, M.-T., Chen, C.-J., Chang, W., Lin, S.-Z., Chen, Y.-L. S., et al. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.124 · Cited by 61 · see citing works
The potential utility of telomere‐related markers for cancer diagnosis
Heaphy, C. M., & Meeker, A. K. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01284.x · Cited by 56 · see citing works
Chatran, M., Pilehvar‐Soltanahmadi, Y., Dadashpour, M., Faramarzi, L., Rasouli, S., Jafari-Gharabaghlou, D., Asbaghi, N. S., & Zarghami, N. (2018) · Drug Research · doi:10.1055/a-0631-8046 · Cited by 56 · see citing works
Salhab, M., Jiang, W. G., Newbold, R. F., & Mokbel, K. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9622-8 · Cited by 54 · see citing works
Self-citationPanis, C., Pizzatti, L., Herrera, A. C. D. S. D. A., Cecchini, R., & Abdelhay, E. S. F. W. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.11.020 · Cited by 51 · see citing works
Kazemi‐Lomedasht, F., Rami, A., & Zarghami, N. (2013) · Europe PMC (PubMed Central) · doi:10.5681/apb.2013.021 · Cited by 50 · see citing works
Telomere‐mediated genomic instability and the clinico‐pathological parameters in breast cancer
Poonepalli, A., Banerjee, B., Ramnarayanan, K., Palanisamy, N., Putti, T. C., & Hande, M. P. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20608 · Cited by 44 · see citing works
The mRNA expression of hTERT in human breast carcinomas correlates with VEGF expression.
Kirkpatrick, K. L., Newbold, R. F., & Mokbel, K. (2004) · Journal of Carcinogenesis · doi:10.1186/1477-3163-3-1 · Cited by 38 · see citing works
Self-citationNasrollahzadeh, A., Bashash, D., Kabuli, M., Zandi, Z., Kashani, B., Zaghal, A., Mousavi, S. A., & Ghaffari, S. H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118060 · Cited by 34 · see citing works
Bertram, C., & Hass, R. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.08.001 · Cited by 33 · see citing works
hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer.
Elkak, A., Mokbel, R., Wilson, C., Jiang, W. G., Newbold, R. F., & Mokbel, K. (2006) · PubMed · Cited by 28 · see citing works
Self-citationYu, H., Xu, S., Lu, W.-H., Li, Y., Li, F., Wang, X., & Su, Y. (2004) · Journal of Surgical Oncology · doi:10.1002/jso.20050 · Cited by 28 · see citing works
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics
Shou, S., Maolan, A., Zhang, D., Jiang, X., Liu, F., Li, Y., Zhang, X., Geer, E., Pu, Z., Hua, B., et al. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00597-9 · Cited by 29 · see citing works
Doloff, J. C., Waxman, D. J., & Jounaïdi, Y. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.056 · Cited by 26 · see citing works
Rahmati‐Yamchi, M., Zarghami, N., Rahbani, M., & Montazeri, A. (2011) · Breast Cancer Basic and Clinical Research · doi:10.4137/bcbcr.s6734 · Cited by 26 · see citing works
Wu, Y. L., Bian, C., Zhen, C., Liu, L., Lin, Z., Nisar, M. F., Wang, M., Bartsch, J. W., Huang, E., Ji, P., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20888 · Cited by 25 · see citing works
Telomerase activation by c-Myc in human mammary epithelial cells requires additional genomic changes
Bazarov, A. V., Hines, W. C., Mukhopadhyay, R., Beliveau, A., Melodyev, S., Zaslavsky, Y., & Yaswen, P. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9856 · Cited by 21 · see citing works
Elkak, A., Meligonis, G., Salhab, M., Mitchell, B., Blake, J., Newbold, R. F., & Mokbel, K. (2005) · Journal of Carcinogenesis · doi:10.1186/1477-3163-4-17 · Cited by 21 · see citing works
Self-citationAdenoviral Vectors for Prodrug Activation-based Gene Therapy for Cancer
Doloff, J. C., & Waxman, D. J. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/18715206113139990309 · Cited by 17 · see citing works
Jenkhetkan, W., Thitiorul, S., Jansom, C., & Ratanavalachai, T. (2017) · Mutagenesis · doi:10.1093/mutage/gex020 · Cited by 16 · see citing works
MYC amplification and TERT expression in breast tumor progression
Böðvarsdóttir, S. K., Steinarsdóttir, M., Hilmarsdóttir, H., Jonasson, J. G., & Eyfjord, J. E. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.04.002 · Cited by 16 · see citing works
Serum human telomerase reverse transcriptase: a novel biomarker for breast cancer diagnosis
Porika, M., Tippani, R., Bollam, S. R., Panuganti, S. D., Thammidala, C. R., & Abbagani, S. (2011) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0230-6 · Cited by 15 · see citing works
Bojović, B., & Crowe, D. L. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.21834 · Cited by 13 · see citing works
An RNA-Seq-Based Gene Expression Profiling of Radiation-Induced Tumorigenic Mammary Epithelial Cells
Ma, L., Nie, L., Liu, J., Zhang, B., Song, S., Sun, M., Yang, J., Yang, Y., Fang, X., Hu, S., et al. (2012) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2012.11.001 · Cited by 13 · see citing works
Hosseini-Asl, S., Atri, M., Modarressi, M. H., Salhab, M., Mokbel, K., & Mehdipour, P. (2006) · International Seminars in Surgical Oncology · doi:10.1186/1477-7800-3-20 · Cited by 13 · see citing works
Self-citationEvaluation of Serum Human Telomerase Reverse Transcriptase as a Novel Marker for Cervical Cancer
Porika, M., Tippani, R., Mohammad, A. M., Bollam, S. R., Panuganti, S. D., & Abbagani, S. (2011) · The International Journal of Biological Markers · doi:10.5301/jbm.2011.6352 · Cited by 12 · see citing works
Morais, K. S., Guimarãesb, A. F. R., Ramos, D. D. A. R., Pittella-Silva, F., & de Oliveira, D. M. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000508 · Cited by 11 · see citing works
Telomerase: is it the future diagnostic and prognostic tool in human cancer?
Mabruk, M. J. E. M. F., & O’Flatharta, C. (2005) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.5.6.907 · Cited by 10 · see citing works
Quantitative analysis of hTERT mRNA levels in cells microdissected from cytological specimens
Fujita, H., Ohuchida, K., Mizumoto, K., Egami, T., Miyasaka, Y., Yamaguchi, H., Yu, J., Cui, L., Onimaru, M., Takahata, S., et al. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00930.x · Cited by 9 · see citing works
Vaccines in Breast Cancer: Challenges and Breakthroughs
Fatima, G. N., Fatma, H., & Saraf, S. K. (2023) · Diagnostics · doi:10.3390/diagnostics13132175 · Cited by 8 · see citing works
There is no correlation between c-Myc mRNA expression and telomerase activity in human breast cancer
Kirkpatrick, K. L., Newbold, R. F., & Mokbel, K. (2004) · International Seminars in Surgical Oncology · doi:10.1186/1477-7800-1-2 · Cited by 8 · see citing works
Self-citationThe TERT Promoter: A Key Player in the Fight for Cancer Cell Immortality
Hasanau, T. N., Pisarev, E., Валерьевна, К. О., & Zvereva, M. I. (2023) · Biochemistry (Moscow) · doi:10.1134/s000629792314002x · Cited by 8 · see citing works
Repullés, J., Anglada, T., Soler, D., Ramı́rez, J. C., Genescà, A., & Terradas, M. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0938 · Cited by 7 · see citing works
Feijing, Z., Sun, Z., Cheng, L., & Dong, Y. (2024) · Laboratory Investigation · doi:10.1016/j.labinv.2024.102169 · Cited by 6 · see citing works
Jeong, Y. J., Park, S.-M., & Jeon, C. (2020) · Oncology Letters · doi:10.3892/ol.2020.11939 · Cited by 6 · see citing works
Murillo-Ortiz, B. O., García-Corrales, K., Martı́nez-Garza, S., Vázquez, M. J. R., Agustín-Godínez, E., Escareño-Gómez, A., Silva-Guerrero, D. G., Mendoza-Ramírez, S., & Murguía‐Pérez, M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1450147 · Cited by 5 · see citing works
Correlation between telomerase gene expression and different stages of breast cancer and obesity
Yamchi, M. R., Nosratallah, Z., Noubar, M. R., Najafipour, R., & Mobasseri, M. (2012) · The Journal of Qazvin University of Medical Sciences · Cited by 3 · see citing works
hTERT-promoter driven oncolytic adenovirus with E1B-19 kDa and E1B-55 kDa gene deletions
Doloff, J. C., Waxman, D. J., & Jounaïdi, Y. (2008) · Human Gene Therapy · doi:10.1089/hgt.2008.056 · Cited by 3 · see citing works
Prominent Prognostic Factors in Aggressive Breast Cancer: A Review
Nejati‐Koshki, K., Aval, S. F., Alivand, M. R., Akbarzadeh, A., & Arabzadeh, A. (2021) · International Journal of Cancer Management · doi:10.5812/ijcm.109015 · Cited by 2 · see citing works
Vakzinierungen in der Therapie des Mammakarzinoms
Gückel, B. (2006) · Der Onkologe · doi:10.1007/s00761-005-0999-x · Cited by 1 · see citing works
Chromosomal alterations and telomere dysfunction in breast tumours
Böðvarsdóttir, S. K. (2008) · Skemman
Kumar, P., Chakroborty, P. K., Wilson, K., Goyal, R., Gupta, S., Saharan, A., Rani, N., & Sharma, P. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947299954240730062858
Diagnostic Value I: Solid Tumors
Hiyama, E., & Hiyama, K. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-879-9_8
- Authors
- Kirkpatrick, K. L., Ogunkolade, W., Elkak, A. E., Bustin, S., Jenkins, P., Ghilchick, M., Newbold, R. F., & Mokbel, K.
- Affiliations
- St George's Hospital (GB)
- Royal London Hospital (GB)
- Brunel University of London (GB)
- Venue
- Breast Cancer Research and Treatment
- Published
- 2003-02
- Volume
- 77
- Issue
- 3
- Pages
- 277-284
- ISSN
- 0167-6806 (ISSN-L)
- 1573-7217
- OpenAlex
- W2074108393
- Cited by
- 53
- References
- 37
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2017: 4 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 5
- FWCI
- 1.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Breast Cancer Research and Treatment (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Keywords
- hTERT, telomerase reverse transcriptase, breast cancer, telomerase reactivation, c-Myc, fibroadenoma, tumor stage, progesterone receptor, tumour biomarkers, breast cancer diagnosis
- MeSH terms
- Breast, Breast Neoplasms, Cell Transformation, Neoplastic, DNA-Binding Proteins, Female, Humans, Neoplasm Staging, RNA, Messenger, Gene Expression Regulation, Neoplastic, Genes, myc, DNA Primers, Telomerase, Reverse Transcriptase Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review